Can pentoxifylline prevent renal disease?

References

• Hammerschmidt DE, Kotasch D, McCarty T. Pentoxifylline inhibits granulocyte and platelet function including priming by plateict activating factor. J Lab Clin Med 1988; 112: 254–262
   PubMed Web of Science ®Google Scholar
• Currie MS, Rao KNK, Padmanabhan J, Jones A, Crawford J, Cohen HJ. Stimulus-specific effects of pentoxifylline on neutrophil CR3 expression, degranulation and superoxide production. J Leukocyte Biology 1990; 47: 244–250
   PubMed Web of Science ®Google Scholar
• Carletto A, Biasi D, Bambara LM, Caramaschi P. Studies of skin window exudate human neutrophils: Increased resistance to pentoxifylline of respiratory burst in promed cells. Inflammation 1997; 21: 191–203
   PubMed Web of Science ®Google Scholar
• Rao KMK, Currie MS, McCachren SS, Cohen HJ. Pentoxifylline and other methylxanthines inhibit interleukin 2 receptor expression in human lymphocytes. Cell Immunology 1991; 135: 314–325
   PubMed Web of Science ®Google Scholar
• Dong RP, Umezawa Y, Ikushima H, Munakata Y, Schlossman SF, Morimoto C. Different regulatory effects of pentoxifylline on human T cell activation pathways. J Clin Immunol 1997; 17: 247–52
   PubMed Web of Science ®Google Scholar
• Hoskin D, Wi Phu T, Makrigiannis AP. Pentoxifylline inhibits granzyme B and perform expression following T lymphocyte activation by antiCD3 antibody. Int J Immunopharmacology 1996; 18: 623–631
   PubMed Web of Science ®Google Scholar
• Btuynzeel I, van der Raaij LM, Willemze R, Stoof TJ. Pentoxifylline inhibits human T cell adhesion to dermal endothelial cells. Arch Dermatol Res 1997; 289: 189–191
   PubMed Web of Science ®Google Scholar
• Schandene L, Vandenbusdse P, Crusiaux A, Alegre ML, Abramowicz D, Dupont E, Content J, Goldman N. Differential effect of pentoxifylline on the production of tumour necrosis factor and 11-6 by monocytes and T cells. Immunology 1992; 76: 30–34
   PubMed Web of Science ®Google Scholar
• Hecht M, Muller M, Lohmann-Matthes NL, Emmendorfe A. In vitro and in vivo effects of pentoxifylline on macrophages and lymphocytes derived from autoimmune MRL lpr/lpr mice. J Leukocyte Biology 1995; 57: 242–249
   PubMed Web of Science ®Google Scholar
• Neuner P, Klosner G, Pourmojib M, Knobler R, Sdnwarz T. Pentoxifylline in vivo and in vitro down-regulates the expression of ICAM-1 in monocytes. Immunology 1997; 90: 435–439
   PubMed Web of Science ®Google Scholar
• Lidington E, Nohammer C, Dominguez M, Ferry B, Rose NL. Inhibition of the trans-endothelial migration of human lymphocytes but not monocytes by phosphodiesterase inhibition. Clin Exp Immunology 1996; 104: 66–71
   PubMed Web of Science ®Google Scholar
• Wardle EN. Neutralizing inflammatory cytokines in nephritis. Nephron 1995; 69: 223–227
   PubMed Web of Science ®Google Scholar
• Moller DR, Wysocka M, Greenlee BM, Ma X, Wahl L, Trinchieri G, Karp CL. Inhibition of human interleukin 12 production by pentoxifylline. Immunology 1997; 91: 197–203
   PubMed Web of Science ®Google Scholar
• Trichiere G. Interleukin 12,a proinflammatory cytokine with immuno-regulatory functions. Ann Review Immunol 1995; 13: 251
   PubMed Web of Science ®Google Scholar
• Ma X, Chow JM, Gri G, Carra G, Gerosa F, Wolf SF, Dzialo R, Trinchieri G. The interleukin 12 p40 gene promoter is primed by interferon-gamma in monocytic cells. J Exp Med 1996; 183: 147
   PubMed Web of Science ®Google Scholar
• Rieckmann P, Weber F, Gunther A, Martin S, Bitseh A. Pentoxifylline a phosphodiesterase inhibitor, induces immune deviation in patients with multiple sclerosis. J Neuro Immunology 1996; 64(2)193–200
   PubMed Web of Science ®Google Scholar
• Kiely PD, Gillespie KM, Oliveira. Oxypentifylline inhibits TNFa mRNA transcription and protects against arthritis in mercuric chloride treated Brown Norway rats. Europ J Immunology 1995; 25: 2899–2906
   PubMed Web of Science ®Google Scholar
• Tsai T-J, Lin P-H, Chang C-C, Chen Y-M, Chen C-F, Ko F-N, Teng C-M. Vasodilator agents modulate rat glomerular mesangial cell growth and collagen synthesis. Nephron 1995; 70: 91–99
   PubMed Web of Science ®Google Scholar
• Schiller AD, Pefrrica L, Gluhovschi GH, Giorgita A, Dan H, Transafirescu V. Effect of pentoxifylline on proteinuria and GFR in patients with chronic glomerulonephritis. Nephrol Dial Transplant 1996; 11: A97
   Google Scholar
• Calderon MJ, Landa N, Aguirre A, Diaz-Perez JL. Successful treatment of cutaneous polyarteritis nodosa with pentoxifylline. British J Dermatol 1993; 128: 706–708
   PubMed Web of Science ®Google Scholar
• Numberg W, Grabbe J, Czametski E. Synergistic effects of pentoxifylline and dapsone in leucocytoclastic vasculitis. Lancet 1994; 343: 491
   Web of Science ®Google Scholar
• Furukawa S, Matsubara T, Umezawa Y. Pentoxifylline and intravenous gamma globulin therapy for acute Kawasaki disease. Europ J Pediatrics 1994; 153: 663–667
   PubMed Web of Science ®Google Scholar
• Campbell RK. Clinical update on pentoxifylline therapy for diabetes induced peripheral vascular disease. Annals Pharmacotherapy 1993; 27: 1099–1105
   PubMed Web of Science ®Google Scholar
• Sonkin PL, Kelly LW, Sinclair SF, Hatdhell DL. Pentoxifylline increases retinal capillary blood flow velocity in patients with diabetes. Archives Ophthal 1993; 111: 1647–1652
   PubMedGoogle Scholar
• Ohdama S, Takano S, Ohashi M, Miyake S, Aoki N. Pentoxifylline prevents tumor necrosis factor induced suppression of endothelial cell surface thrombomodulin. Thrombosis Res 1991; 62: 745–755
   PubMed Web of Science ®Google Scholar
• Guerrero-Romero F, Rodriguez-Moran M, Paniagua-Sierra JR, Garcia-Bulnes G, Salas-Ramirez M, Amato D. Pentoxifylline reduces proteinuria in non-insulin dependent diabetes patients. Clin Nephrology 1995; 43: 116–121
   PubMed Web of Science ®Google Scholar
• Murrel GA, Francis M J, Bromley L. Modulation of fibroblast proliferation by oxygen free radicals. Biochem J 1990; 265: 659–665
   PubMed Web of Science ®Google Scholar
• Poll G, Panola M. Oxidative dainage and fibrogenesis. Free Radical Biol Med 1997; 22: 287–305
   PubMed Web of Science ®Google Scholar
• Franzini B, Sellak H, Marquetty C, Babin-Chevaye C, Hakim J, Pasquier C. Inhibition of human neutrophil binding to hydrogen peroxide treated endothelial cells by cAMP and hydroxyl radical scavengers. Free Rad Biol Med 1996; 21: 15–23
   PubMed Web of Science ®Google Scholar
• Fine A, Poliks CF, Donahue LP, Small BD, Goldstein RH. Differential effect of prostaglandin E2 on TGF beta and insulin induced collagen formation in lung fibroblasts. J Biol Chem 1989; 264: 16988–16996
   PubMed Web of Science ®Google Scholar
• Windmeier C, Grassier AM. Effect of pentoxifylline on the fibrogenic functions of cultured rat liver fat storing cells and myofibroblasts. Biochem Pharmacol 1996; 51: 577–584
   PubMed Web of Science ®Google Scholar
• Peterson TC. Inhibition of fibroproliferation by pentoxifylline. Biochem Pharmacol 1996; 52: 597–602
   PubMed Web of Science ®Google Scholar
• Reichert LJM, Koene R, Wetzels J. Urinary excretion of β2-microglobulin predicts outcome in patients with idiopathic membranous nephropathy. J Amer Soc Nephrology 1995; 6: 1666–1669
   PubMed Web of Science ®Google Scholar